CNMR, and mass spectra.
INTRODUCTION
Citrullus colocynthis (L.) is an important medicinal plant belonging to the family cucurbitaceae. It is an annual herb widely distributed in Mediterranean strip (Tackholm, 1974) . The plant is prostrate, herbaceous characterized by 5-angled stems and coiled tendrils, leaves alternate, palmately 5-lobed or divided, exstipulate and flowers are unisexual and solitary (Täckholm, 1974; Chaudhary and Al-jowaid, 1999) . Nowadays, medicinal plants receive attention to research centers because of their special importance in safety of communities. The curative properties of medicinal plants are mainly due to the presence of various complex chemical substances of different composition which occur as secondary metabolites (Karthikeyan et al., 2009) . Several active chemical constituents of C. colocynthis plant were recorded. They are grouped as alkaloids, flavonoids, saponins, tannins, carbohydrates, glycosides and essential oils. Plant based natural constituents can be derived from any part of the plant like stems, leaves, flowers, roots, fruits and seeds (Gordon and David, 2001) . A number of plant secondary metabolites including flavonoids and curcubitacins have previously been reported from C. colocynthis (Maatooq et al., 1997; Seger et al., 2005) . Adam et al. (2001) reported the bitter substances (colocynthin and colocythetin) and cucurbitacins A, B, C, D and E (α -elatrin); cucurbitacines E, I, J, K and L (Sturm et al., 2009) , cucurbitacin glycosides (Hatam et al., 1989; Abbas et al., 2006) . The cucurbitacins are of great interest because of the wide range of biological activities exhibited in plants and animals. They are predominantly found in the Cucurbitaceae family. A number of chemical constituents have been investigated for their cytotoxic, heptoprotective, cardiovascular and antidiabetic effects and antioxidant activity of cucurbitacins B and I (Jayaprakasam et al., 2003) and the glucosides of cucurbitacin I and L (Abbas et al., 2006) . Sunil et al. (2008) studied antioxidant and free radical scavenging potential of C. colocynthis methanolic fruit extract. C. colocynthis is also one of the plants belonging to family cucurbitaceae. It is a fruit commonly known as bitter apple. It is a native plant of North Africa, being common throughout Morocco, Egypt and Sudan (AlGhamdi et al., 2009) . It has been used in herbal treatment of diabetes (Karim et al., 2011) , edema, bacterial infection and cancer. The aqueous pulp extract of fruit is used for kidney, liver functions treatment (Rahbar and Nabipour, 2010) . The phenolic compounds isolated from plants are of great interest due to their antioxidative and anticarcinogenic activity. They play a very important role in absorbing and neutralizing free radicals. They contain not only minerals and primary metabolite but also a diverse array of secondary metabolite with antioxidant potential (Chanda et al., 2011) .
In the present investigation of C. colocynthis, we report the isolation and structural elucidation of two new alkaloids 1, 2 and two flavonoids 3, 4 that has not been previously investigated with respect to its alkaloid and flavonoid constituents. 
MATERIALS AND METHODS

General procedures
UV shift reagents were prepared according to standard procedures (Mabry et al., 1970; Markham, 1982 
Plant materials
The aerial parts of C. colocynthis were collected in June 2010 from plants growing wild in the Mediterranean Coastal Strip, Egypt. The plant identify was verified by plant taxonomist. A voucher specimen has been deposited at the Herbarium of the Botany Department, Faculty of Science, Cairo University. The collected plant samples of C. colocythis were washed with distilled water and then air dried for two weeks. The dried samples were homogenized with electrical grinder and finally stored in airtight bottles before analysis.
Extraction and isolation
Dried and powdered aerial parts (1 kg) were extracted with MeOH and the extract evaporated to dryness under reduced pressure. The residue (2.5 g) was acidified with 0.1 N H2SO4 and extracted with CHCl3. The acid soluble part was basified with NH4OH (Balbaa et al., 1981) and extracted with CHCl3. The CHCl3 extract (1.3 g) was fractionated on a basic AL2O3 column (5 × 70 cm) eluting with hexane (fraction A), followed by a gradient of CH2Cl2 and ethyl acetate up to 100% (fraction B). Fraction A had yielded compound 1 (75 mg) and fraction B has compound 2 (35 mg). Dried aerial parts of C. colocynthis (500 g) were extracted with MeOH for 6 h. The collected methanol (MeOH) extracts were concentrated to dryness under reduced pressure. The residue (4.5 g) was partitioned between 1 : 1 EtOAc / H2O. The EtOAc layer was concentrated to give residue (3.4 g) and then applied to silica gel column eluted with n -hexane -EtOAc (1 : 1). The fraction was applied to a porous polymer Diaion HP -20 (H2O -MeOH gradient) followed by MPLC silica gel, (CH2Cl2 -MeOH gradient) to give compound 3 (35 mg) and compound 4 (25 mg).
Identification of compounds
Compound (1) , 2850, 1710, 1640, 1595, 1560, 1510, 1460, 1420, 1360, 1190, 1160, 1120, 990, 840, 760. 1 H and 13 CNMR (CDCl3) are tabulated in Table 1 ): 2930, 2850, 1705, 1595, 1565, 1510, 1450, 1430, 1370, 1190, 1150, 1140, 1000, 980, 840, 760. 1 H and 13 CNMR (CDCl3) resulted as shown in 
RESULTS AND DISCUSSION
Two new alkaloids (compounds 1 and 2) were isolated from the aerial parts of C. colocynthis. The UV spectra for compound 1 showed typical 4-quinolone peaks at 332, 320, 236 and 216 nm. The IR spectrum showed aromatic signals at 1595 and 1510 cm -1 . The 1 HNMR spectra of compound 1 showed quinolone structure with the broad doublet. Also the 1 HNMR spectrum showed the signals for the aliphatic side chain as given in Table 1 . The placement of the side chain was decided by HMBC experiment for compounds 1 and 2. 13 CNMR (Table 1) . From the HMBC experiments the structure of compound 1 was assigned as 2-(nonan-8-one)- (1H) . The UV spectrum showed the presence of conjugated aromatic system with the maxima at 312 (sh), 300 and 228 nm. The correlation of the protons and carbons were followed from the HMBC spectrum and unambiguous assignment of the molecule (Table 1 ). The spectral data showed the structure of compound 2 as 2-(nonan-8-one)-4-methoxy-quinoline (Figure 1) . Furthermore, two flavonoids were isolated from aerial parts of the plant. These were identified as (2S)-3 \ , 4 \ -methylenedioxy-5, 7-dimethoxy flavan (Figure 2 , compound 3) and hispidulin 7-(6-E-P-coumaroyl-β-Dglucopyranoside) (Figure 2, compound 4) . The molecular formula of compound 3 was determined as C 18 H 18 O 5 on the basis of HR-MS. The broad band decoupled 13 CNMR spectrum showed 18 carbon signals. The IR spectrum showed absorption bands at 1595 and 1495 cm -1 which were assignable to an aromatic ring. The aforementioned data and UV spectrum (λ max) at 230 and 283 nm (sh) suggested aflavan nature for compound 3, which was further evidenced by the analysis of the HNMR spectrum showed proton signals at δ 6.07 and 6.11. Also, the proton signals were at δ 6.76, 6.87 and 6.92. The H-2, H 2 -3 and H 2 -4 signals were at (δ 4.87), (δ 1.96, 2.13) and (δ 2.61, 2.73), respectively. Additionally, the existence of an E-P-coumaroyl group in compound 4. The downed field shifted H-6 \\ resonance suggested that the E-P-coumaroyl moiety was adjacent to C-6 \\ . Finally, through HMBC results, the attachment positions were determined. The methoxyl signal at δ 3.66 (s, 6 -OMe) showed at 3 J correlation to a carbon at δ 132.6 (C-6) suggesting the methoxl group was connected to C-6 position in hispidulin moiety. The anomeric proton of the glucose unit (δ 5.30, H-1 \\ ) showed a 3 J correlation to a carbon of hispidulin (δ 157.6, C-7) indicating the attachment of the glucoside group at position C-7. Further, a 3 J interaction between H-6 \\ of the glucose (δ 4.30, H-6 \\ ) and the P-coumaroyl carbonyl carbon (δ 166.7, C-9 \\\ ) suggested the attachment of the Pcoumaroyl ester at C-6 \\ of the glucose moiety (Figure 2 ). From the aforementioned evidences, the structure of compound 4 was determined to be hispidulin 7-(6-E-Pcoumaroyl-β-D-glucopyranoside).
